主管单位:中华人民共和国
国家卫生健康委员会
总编辑:杨秋
编辑部主任:吴翔宇
邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)
英文作者:Tian Jinfan Luo Hanzhong Liu Libo An Ziyu Song Xiantao
单位:首都医科大学附属北京安贞医院心内冠心病中心一区,北京100029
英文单位:The First Ward of Coronary Heart Disease Center Department of Cardiology Beijing Anzhen Hospital Capital Medical University Beijing 100029 China
英文关键词:Ginkgobilobaextract;Atherosclerosis;Inflammation;Oxidativestress
银杏叶提取物作为中国传统中药具有抗炎症、抗氧化、维持细胞生存、抑制血小板活化、扩张血管以及调节代谢等作用,广泛应用于临床治疗多种心血管疾病,尤其是动脉粥样硬化。在动脉粥样硬化治疗中,银杏叶提取物可以通过作用于5′-磷酸腺苷活化蛋白激酶-蛋白激酶B、丝裂原活化蛋白激酶、磷脂酰肌醇-3-激酶-蛋白激酶B、核因子E2相关因子-血红素加氧酶1多种通路发挥保护效应。本文对银杏叶提取物治疗动脉粥样硬化的机制及临床应用作一综述。
Ginkgo biloba extract (GBE), as a traditional Chinese medicine, has the functions of anti-inflammation, anti-oxidation, maintaining cell survival, inhibiting platelet activation, dilating blood vessels and regulating metabolism. It is widely used in clinical treatment of a variety of cardiovascular diseases, especially atherosclerosis. In the treatment of atherosclerosis, GBE can play a protective effect by acting on multiple pathways including 5′-adenosine monophosphate-activated protein kinase/protein kinase B, mitogen-activated protein kinase, phosphatidylinositol-3-kinase/protein kinase B, nuclear factor E2-related factor/heme oxygenase-1. This article reviews the mechanism and clinical application of GBE in the treatment of atherosclerosis.
copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。